GlucoTrack Inc. (NASDAQ: GCTK)
$0.1498
+0.0328 ( +5.87% ) 612.7M
GlucoTrack Inc is a medical device company. It focuses on the design, development, and commercialization of non-invasive glucose monitoring devices for use by people with diabetes and pre-diabetics. The company has developed a non-invasive glucose monitor, the GlucoTrack model DF-F glucose monitoring device, which is designed to help people with diabetes and pre-diabetics obtain glucose level readings without the pain, inconvenience, and difficulty of conventional spot finger stick devices. It has completed a feasibility study successfully demonstrating that a minimum two-year implant life is highly probable with the sensor design. They have also initiated an animal study with an initial prototype system that has thus far demonstrated a simple implant procedure and good functionality.
Market Data
Open
$0.1498
Previous close
$0.1170
Volume
612.7M
Market cap
$2.20M
Day range
$0.1300 - $0.1850
52 week range
$0.1100 - $4.9500
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 17 | Jul 31, 2024 |
8-k | 8K-related | 14 | Jul 22, 2024 |
8-k | 8K-related | 42 | Jul 08, 2024 |
4 | Insider transactions | 2 | Jul 03, 2024 |
4 | Insider transactions | 2 | Jul 03, 2024 |
8-k | 8K-related | 16 | Jul 01, 2024 |
8-k | 8K-related | 16 | Jun 20, 2024 |
8-k | 8K-related | 15 | Jun 13, 2024 |
8-k | 8K-related | 13 | May 24, 2024 |
8-k | 8K-related | 14 | May 20, 2024 |